Federal contractor · TUSCALOOSA, AL

EVIMERO, LLC

EVIMERO, LLC received $597.5K in federal contract obligations in FY2026, on 1 awards. Its largest customer was Departmental Offices ($597.5K).

Obligations · FY2026
$597.5K
New awards
1
Sole-source
0.0%
Single offer
0.0%
UEI
UUN7YGXQPAJ9
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 597.5KFY2026

Top buying agencies

Obligations in FY2026.

  1. Departmental Offices$597.5K100%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$597.5K100%

Where the work was performed

  1. Tuscaloosa County, AL$597.5K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.8% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. LEVERAGING THE GUT MICROBIOME AS AN INTEGRATOR OF NUTRITIONAL STATUS: A FEASIBILITY STUDY OF MICROBIOME NUTRITIONAL DIAGNOSTICS (MINU-DX)$597.5K
    Departmental Offices· Tuscaloosa County, AL· Research & development· Mar 4, 2026 – Jul 21, 2026· 140D0426C0003

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

EVIMERO, LLC received $0 in federal assistance in FY2026, on 2 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
2
Since FY2024
$325.1K

Assistance by fiscal year

  1. 325.1KFY2024
  2. 0FY2026

Largest awards

  1. TARGETED IMMUNOTHERAPEUTICS IN DYSBIOTIC MICROBIOMES - A FEASIBILITY AND PROOF-OF-CONCEPT STUDY - PROJECT SUMMARY ABSTRACT EVIMERO NCATS P1…$325.1K
    93.350 · National Center for Advancing Translational Sciences· National Institutes of Health· Project grant· Aug 7, 2024 – Jan 28, 2026· R43TR005333

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2024–FY2026.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. ALETHIUM TECHNOLOGIES, INC.$598K
    WEST HOLLYWOOD, CA · 100% of this company's obligations are in markets they both serveDepartmental Offices · Scientific research and development services
  2. ZENSO INC$599.3K
    BERKELEY, CA · 100% of this company's obligations are in markets they both serveDepartmental Offices · Scientific research and development services
  3. GT BIOSCIENCES, INC.$600K
    CAMBRIDGE, MA · 100% of this company's obligations are in markets they both serveDepartmental Offices · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.